Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Home
/
Trials
/
NCT00002298
NCT00002298
View on ClinicalTrials.gov
The Safety and Effectiveness of Ribavirin in the Early Stages of HIV-Infection
NA
Terminated
INTERVENTIONAL
Timeline
Start Date
Not specified
Conditions
HIV Infections
Interventions
DRUG
Ribavirin
Sponsors
Lead Sponsor
ICN Pharmaceuticals
All Listed Sponsors
lead
ICN Pharmaceuticals
INDUSTRY